Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Sep 4, 2024 · CIK: 1266806
Sentiment: neutral
Topics: 8-K, filing, corporate-events
TL;DR
Vivani Medical filed an 8-K on Sept 4th, check for updates.
AI Summary
Vivani Medical, Inc. filed an 8-K on September 4, 2024, reporting other events and financial statements. The company, formerly known as Second Sight Medical Products Inc., is incorporated in Delaware and headquartered in Alameda, California.
Why It Matters
This filing indicates ongoing corporate reporting and potential updates regarding Vivani Medical's financial status and operational events.
Risk Assessment
Risk Level: low — This is a routine filing reporting corporate events and financial statements, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-36747 — Commission File Number (Identifies the company's SEC filing record)
- 02-0692322 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- Second Sight Medical Products Inc. (company) — Former company name
- September 4, 2024 (date) — Date of earliest event reported
- Alameda, California (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' are being reported, but the specific details of these events are not provided in the header information.
What is the significance of filing 'Financial Statements and Exhibits'?
This indicates that the company is providing updated financial information and supporting documents as required by the SEC.
When did Vivani Medical, Inc. change its name from Second Sight Medical Products Inc.?
The filing lists the date of name change as October 10, 2003.
What is the primary business of Vivani Medical, Inc. based on its SIC code?
Vivani Medical, Inc. is classified under SIC code 3845, which pertains to Electromedical & Electrotherapeutic Apparatus.
Where are Vivani Medical, Inc.'s principal executive offices located?
The principal executive offices are located at 1350 S. Loop Road, Alameda, California 94502.
Filing Stats: 518 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-09-04 08:16:34
Filing Documents
- vani-20240904.htm (8-K) — 36KB
- ex991_1.htm (EX-99.1) — 25KB
- imgb00a1692113f4c5a8152.jpg (GRAPHIC) — 8KB
- imgf6bf26075fdd43d3b7ec.jpg (GRAPHIC) — 9KB
- 0001753926-24-001531.txt ( ) — 282KB
- vani-20240904_def.xml (EX-101.DEF) — 1KB
- vani-20240904_pre.xml (EX-101.PRE) — 29KB
- vani-20240904_cal.xml (EX-101.CAL) — 1KB
- vani-20240904_lab.xml (EX-101.LAB) — 42KB
- vani-20240904.xsd (EX-101.SCH) — 4KB
- vani-20240904_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On September 4 , 202 4 , Vivani Medical, Inc . (the "Company") announced positive preclinical liver fat results with the Company's GLP-1 ( exenatide ) implant. The c linical development of the Company's GLP-1 ( exenatide ) implant in overweight and obese patients as part of the Company's NPM -115 program remains on track to commence in the fourth quarter of 2024 . A copy of the press release issued in connection with this announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Vivani Medical, Inc. on September 4 , 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) .
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: September 4 , 2024 By: /s/ Donald Dwyer Name: Donald Dwyer Title: Chief Financial Officer